YKY. Kikuchi

Y. Kikuchi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Y. Kikuchi has a total of 23 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Development and evaluation of high-resolution gamma camera for animal imaging

    by Y. Kikuchi, N. Koshikawa, K.S. Tanaka, J. Kataoka

    In recent years, 211At has garnered significant attention in the field of targeted radionuclide therapy, owing to its potential for localized and highly effective cancer treatment. This alpha-emitting radionuclide is particularly promising as it emits alpha particles with 100% probability and can be produced easily in cyclotron facilities. Additionally, 211At emits 79 keV X-rays, which can be used for imaging purposes. Imaging these X-rays enables tracking of 211At dynamics, which is critical for visualizing therapeutic effects and optimizing treatment strategies. Consequently, the development of high-resolution imaging technologies for 211At is of great importance. Currently, human SPECT systems are used for 211At imaging in animal studies and typically provide a resolution of 5–10 mm. However, the small size of the organs in animals necessitates a resolution below 1 mm for detailed imaging. Although various high-resolution imaging devices have been proposed, achieving a balance among high resolution, low cost, and ease of use remains a challenge. To address this need, we are developing an easy-to-use, affordable, and high-resolution gamma camera with an active area of 100 × 100 mm2, specifically designed for small-animal imaging. The detector incorporates four 50 × 50 mm2 multi-pixel photon counter arrays optically coupled to diced Gd3Al2Ga3O12 scintillators with a pixel size of 0.5 mm. The system was designed to target low-energy X-rays and gamma rays, including the 79 keV X-rays emitted from 211At. We conducted experiments using 133Ba and 241Am sources, that emit low-energy gamma rays. Our resolution evaluation demonstrated the ability to resolve 0.6 mm slits. In addition, we confirmed the capability of the detector for imaging complex radiation sources.


  • Proposal and demonstration of a novel SPECT for high-precision gamma-ray imaging

    by N. Koshikawa, Y. Kikuchi, S. Uno, K.S. Tanaka, M. Murakami, Y. Kadonaga, A. Toyoshima, K. Takamiya, J. Kataoka

    In nuclear medicine, there is a growing demand for imaging the pharmacokinetics of various therapeutic drugs. Although there are promising radiopharmaceuticals that emit gamma rays of several hundred keV, imaging devices offering high contrast and spatial resolution in this energy range have not yet been developed. Compton cameras perform imaging in high-energy regions, including several hundred keV and even higher than MeV; however, their spatial resolution is relatively low. Single-photon emission computed tomography (SPECT) offers high spatial resolution for imaging with X-rays and gamma rays below 200 keV. However, thick collimator walls are required for imaging in high-energy regions, leading to limited statistics and low image contrast. Therefore, we developed a high-contrast SPECT (HC-SPECT) system capable of high-contrast and high-resolution imaging using gamma rays in a several hundred keV range. We developed a collimator with an array of hourglass-shaped holes that efficiently collect gamma rays while maintaining the thickness of the collimator walls to prevent noise events. In this study, a prototype HC-SPECT system was developed, and its performance was compared with that of a Compton camera and parallel-hole SPECT.

  • Open Access

    Activation imaging of gold nanoparticles for versatile drug visualization: An in vivo demonstration

    by N. Koshikawa, Y. Kikuchi, K. S. Tanaka, K. Tokoi, A. Mitsukai, H. Aoto, Y. Kadonaga, A. Toyoshima, H. Kato, K. Ooe, et al.

    Gold nanoparticles (AuNPs) have recently attracted considerable attention as promising drug carriers. In vivo imaging of AuNPs is required to investigate their pharmacokinetics. However, a direct and highly sensitive method has not yet been established. Therefore, we proposed the activation imaging of AuNPs that radioactivates AuNPs and non-invasively visualizes them using the emitted gamma rays. When the stable isotope of gold, 197Au, is irradiated with low-energy neutrons, it changes to radioactive 198Au, which predominantly emits 412-keV gamma rays. In this study, we synthesized [198Au]AuNPs through neutron irradiation and intratumorally injected them into tumor-bearing mice. In vivo imaging was performed using wideband x rays and gamma rays imager, and the distribution of [198Au]AuNPs in the body of mice was observed. Furthermore, we labeled the alpha-emitting therapeutic drug 211At with [198Au]AuNPs. Although 211At itself can be visualized using its 79-keV x rays, the long-term tracking of 211At-labeled AuNPs has been challenging due to its relatively short half-life of 7.2 h. The activation of AuNPs enables the long-term tracking of 211At-labeled AuNPs owing to the 2.7-day half-life of 198Au. 211At-labeled [198Au]AuNPs were injected intravenously into mice and visualized using a wideband x rays and gamma rays imager. Simultaneous imaging of 211At and 198Au was performed on the day of injection and 2 days after injection. Although 211At could no longer be imaged 2 days after injection, the distribution of the drug was visualized using gamma rays from 198Au.


  • High-contrast Compton camera: Challenges to high-quality and broadband imaging

    by N. Koshikawa, Y. Kikuchi, Y. Wakabayashi, T. Kobayashi, J. Kataoka

    In the field of nuclear medicine, various radiopharmaceuticals require wideband x-ray/gamma-ray imaging devices for clinical and treatment monitoring. Compton cameras, which perform imaging using high-energy gamma rays, have the potential to significantly increase the variety of radioactive nuclides that can be imaged. However, artifacts caused by the so-called “Compton cone” have hindered their clinical use. Therefore, we propose the use of a collimator to improve the contrast of images obtained using Compton cameras. In this study, we developed a high-contrast Compton camera by attaching a tungsten collimator to its front surface. The contrast is improved by applying weighting to the signals based on the distance that the high-energy gamma rays penetrated the collimator walls. As a demonstration, we visualized 198Au plates that emit 412-keV gamma rays with and without the collimator. In addition, low-energy (<200 keV) x-ray/gamma-ray imaging, which is difficult for conventional Compton cameras, was achieved by performing single-photon emission computed tomography (SPECT) using the collimator and scatterer of the Compton camera. We demonstrated broadband gamma-ray imaging by visualizing a 133Ba standard source using 81-keV and 356-keV gamma rays based on the principles of SPECT and Compton cameras, respectively.